Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus.

Antiviral Res.
Pitts JD, Li PC, de Wispelaere M, Yang PL.
| 10 16, 2017
3.

Discovery of host-targeted covalent inhibitors of dengue virus.

Antiviral Res.
de Wispelaere M, Carocci M, Liang Y, Liu Q, Sun E, Vetter ML, Wang J, Gray NS, Yang PL.
| 12 26, 2016
4.

Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins.

Antiviral Res.
Beelontally R, Wilkie GS, Lau B, Goodmaker CJ, Ho CM, Swanson CM, Deng X, Wang J, Gray NS, Davison AJ, Strang BL.
| 12 09, 2016
5.

Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo.

Antiviral Res.
Warfield KL, Warren TK, Qiu X, Wells J, Mire CE, Geisbert JB, Stuthman KS, Garza NL, Van Tongeren SA, Shurtleff AC, Agans KN, Wong G, Callahan MV, Geisbert TW, Klose B, Ramstedt U, Treston AM.
| 11 28, 2016
6.

Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses.

Antiviral Res.
Carocci M, Yang PL.
| 02 10, 2016
7.

Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses.

Antiviral Res.
Villareal VA, Rodgers MA, Costello DA, Yang PL.
| 10 23, 2015
8.

Heparin octasaccharide decoy liposomes inhibit replication of multiple viruses.

Antiviral Res.
Hendricks GL, Velazquez L, Pham S, Qaisar N, Delaney JC, Viswanathan K, Albers L, Comolli JC, Shriver Z, Knipe DM, Kurt-Jones EA, Fygenson DK, Trevejo JM, Wang JP, Finberg RW.
| 01 28, 2015
9.

A path to eradication of hepatitis C in low- and middle-income countries.

Antiviral Res.
Graham CS, Swan T.
| 01 20, 2015
10.

Inhibition of large T antigen ATPase activity as a potential strategy to develop anti-polyomavirus JC drugs.

Antiviral Res.
Randhawa P, Zeng G, Bueno M, Salgarkar A, Lesniak A, Isse K, Seyb K, Perry A, Charles I, Hustus C, Huang M, Smith M, Glicksman MA.
| 10 15, 2014
11.

Entry inhibitors and future treatment of hepatitis C.

Antiviral Res.
Fofana I, Jilg N, Chung RT, Baumert TF.
| 02 10, 2014
16.

Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants.

Antiviral Res.
Pelosi E, Mulamba GB, Coen DM.
| 3 13, 1998
17.

Animal models for anti-AIDS therapy.

Antiviral Res.
Koch JA, Ruprecht RM.
| 8 1, 1992
  • Prev
  • 1
  • Next

Search